Nuveen
MYOK

Nuveen’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Nuveen’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-254,473
Closed -$34.7M – 3393
2020
Q3 		$34.7M Sell
254,473
-15,684
-6% -$1.67M 0.01% 732
2020
Q2 		$26.1M Buy
270,157
+68,400
+34% +$5.71M 0.01% 877
2020
Q1 		$9.46M Buy
201,757
+3,550
+2% +$227K ﹤0.01% 1325
2019
Q4 		$14.4M Sell
198,207
-7,862
-4% -$477K 0.01% 1367
2019
Q3 		$10.7M Sell
206,069
-19,544
-9% -$1.04M ﹤0.01% 1522
2019
Q2 		$11.3M Buy
225,613
+217,199
+2,581% +$10.6M ﹤0.01% 1521
2019
Q1 		$437K Sell
8,414
-4,540
-35% -$209K ﹤0.01% 856
2018
Q4 		$633K Hold
12,954
– – ﹤0.01% 783
2018
Q3 		$845K Buy
12,954
+257
+2% +$15.1K ﹤0.01% 771
2018
Q2 		$630K Buy
+12,697
New +$615K ﹤0.01% 832

Nuveen's MYOK Position: Q4 2020 in Review

Nuveen sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 254,473 shares — an estimated $34.7M sold.

Nuveen first reported a position in MYOK in Q2 2018 and held it in 10 quarters. The position peaked at $34.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Nuveen reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Nuveen sold 254,473 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $34.7M.
  • Nuveen first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
  • Nuveen's MyoKardia, Inc. Common Stock position peaked at $34.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.